NIH-funded research R01 grant

Improving colorectal cancer screening using advanced imaging technology

Official title: Colorectal Cancer Screening with Optical Coherence Tomography

Funded at Massachusetts General Hospital · NIH-10979884 · Data updated 2026-11-12

This study is testing a new imaging technology called optical coherence tomography (OCT) to make colorectal cancer screenings better by helping doctors see hard-to-reach areas in the colon, which could lead to more accurate polyp detection and a more comfortable, less invasive experience for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$710,880
NIH project number1R01CA280972-01A1
Project IDNIH-10979884 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals undergoing routine colorectal cancer screening, particularly those at higher risk for adenomas.

Less likely to help

Patients who have already been diagnosed with colorectal cancer or those who are not eligible for screening may not benefit from this research.

What this research studies

This research focuses on enhancing colorectal cancer screening by utilizing optical coherence tomography (OCT), a cutting-edge imaging technology. The goal is to develop a system that allows for better visualization of the entire colon, including areas that are typically hard to see, such as behind mucosal folds. By improving the sensitivity and accuracy of polyp detection, this approach aims to reduce the number of missed adenomas and the associated costs of traditional colonoscopy procedures. Patients may benefit from a less invasive screening method that does not require sedation and can provide real-time diagnosis.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and cost-effective colorectal cancer screenings, ultimately reducing cancer incidence and improving patient outcomes.

How similar studies have gone: Previous research has shown promise in using advanced imaging technologies for cancer detection, indicating that this approach could be a significant advancement in colorectal cancer screening.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Tearney, Guillermo J — Massachusetts General Hospital
  • Study coordinator: Tearney, Guillermo J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.